Clinical Trials Logo

Clinical Trial Summary

The current study is aimed at determining the normal response to increasing heart rates. For this purpose, atrial pacing will be used to increase heart rate.


Clinical Trial Description

Participants will be patients with pacemakers and normal A-V node conduction with a possibility for right atrial pacing mode.

Detailed Echo studies will be performed at baseline. Echo studies will be repeated at each pacing stage, stages defined as 10 bpm increments in paced heart rate. Each stage will last 2-3 min or as long as it takes to record the echo study. Heart rate will be increased to 85% of predicted heart rate for age or at to appearance of signs of ischemia.

Hemodynamic parameters will be recorded and segmental longitudinal strain will be calculated (as well as other Echo data), for each stage. ;


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01112176
Study type Interventional
Source Hillel Yaffe Medical Center
Contact David S. Blondheim, MD
Phone 97246304488
Email davidb@hy.health.gov.il
Status Recruiting
Phase N/A
Start date April 2010
Completion date April 2012

See also
  Status Clinical Trial Phase
Recruiting NCT05553314 - Carvedilol in HF With Preserved EF Phase 4
Completed NCT03776682 - Myocardial Inflammation in Rheumatoid Arthritis: A Descriptive Study
Recruiting NCT04347434 - Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI Phase 4